Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.

ClinicalTrials.gov ID: NCT04049266

Public ClinicalTrials.gov record NCT04049266. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b/3, Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center Study to Investigate the Efficacy and Safety of Repeated Intravitreal Administration of KSI-301 in Subjects With Neovascular (Wet) Age-related Macular Degeneration.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy, safety, durability, and pharmacokinetics of KSI-301 administered at 12, 16 and 20 weeks intervals as specified in the protocol, compared with aflibercept once every 8 weeks (Q8W), in participants with treatment-naïve neovascular (wet) age-related macular degeneration (nAMD).

Study identification

NCT ID
NCT04049266
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Kodiak Sciences Inc
Industry
Enrollment
559 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 8, 2019 (Actual)
Primary completion
Nov 17, 2021 (Actual)
Completion
Apr 26, 2022 (Actual)
Last update posted
Jul 18, 2024

2019 – 2022

United States locations

U.S. sites
59
U.S. states
23
U.S. cities
56
Facility City State ZIP Site status
Retinal Research Institute, LLC Phoenix Arizona 85014 —
Northwest Arkansas Retina Associates Springdale Arkansas 72762 —
California Retina Consultants Bakersfield California 93309 —
Retina Vitreous Associates Beverly Hills California 90211 —
Eye Medical Center of Fresno Fresno California 93720 —
Retina Consultants of Orange County Fullerton California 92835 —
UCSD Jacobs Retina Center La Jolla California 92037 —
Retina Associates of Orange County Laguna Hills California 92653 —
Northern California Retina Vitreous Associates Mountain View California 94040 —
Retina Consultants of San Diego Poway California 92064 —
Retinal Consultants Medical Group Inc Sacramento California 95819 —
Orange County Retina Medical Group Santa Ana California 92705 —
California Retina Consultants Santa Maria California 93454 —
Colorado Retina Associates PC Lakewood Colorado 80228 —
Florida Eye Microsurgical Institute Boynton Beach Florida 33426 —
Rand Eye Institute Deerfield Beach Florida 33064 —
Retina Health Center Fort Myers Florida 33907 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
Florida Eye Associates Melbourne Florida 32901 —
Retina Specialty Institute Pensacola Florida 32503 —
Retina Vitreous Associates of Florida St. Petersburg Florida 33703 —
Retina Associates of Florida Tampa Florida 33609 —
Southeast Retina Center Augusta Georgia 30909 —
Wolfe Eye Clinic West Des Moines Iowa 50266 —
Retina Associates PA Lenexa Kansas 66215 —
Vitreo Retinal Consultants and Surgeons Wichita Kansas 67214 —
Retina Associates of Kentucky Lexington Kentucky 40509 —
Cumberland Valley Retina Consultants PC Hagerstown Maryland 21740 —
New England Retina Consultants Springfield Massachusetts 01103 —
Vitreo Retinal Associates PC Worcester Massachusetts 01603 —
Foundation for Vision Research Grand Rapids Michigan 49525 —
Associated Retinal Consultants PC Royal Oak Michigan 78073 —
Vitreoretinal Surgery PA Edina Minnesota 55435 —
Springfield Clinic LLP Springfield Missouri 62703 —
Sierra Eye Associates Reno Nevada 89502 —
The Retina Center of New Jersey Bloomfield New Jersey 07017 —
NJ Retina Teaneck New Jersey 07605 —
Retina Associates of Cleveland Beachwood Ohio 44122 —
Retina Associates of Cleveland Cleveland Ohio 44130 —
Cleveland Clinic Foundation, Cole Eye Institute Cleveland Ohio 44195 —
Retina and Vitreous Center of Southern Oregon PC Ashland Oregon 97520 —
Cascade Medical Research Institute Eugene Oregon 97401 —
Retina Northwest Portland Oregon 97210 —
Wills Eye Hospital Philadelphia Pennsylvania 19107 —
Palmetto Retina Center Florence South Carolina 29501 —
Charleston Neuroscience Institute Ladson South Carolina 29456 —
Black Hills Regional Eye Institute Rapid City South Dakota 57701 —
Southeastern Retina Associates PC Knoxville Tennessee 37909 —
Tennessee Retina PC Nashville Tennessee 37203 —
Retina Research Institute of Texas Abilene Texas 79606 —
Austin Clinical Research, LLC Austin Texas 78705 —
Austin Retina Associates Austin Texas 78705 —
Retina Consultants of Texas Bellaire Texas 77401 —
Retina Consultants of Texas (Katy) Katy Texas 77494 —
Texas Retina Associates Plano Texas 75075 —
Austin Retina Associates (Round Rock) Round Rock Texas 78681 —
Medical Center Ophthalmology Associates San Antonio Texas 78240 —
Retina Consultants of Texas (Woodlands) The Woodlands Texas 77384 —
Strategic Clinical Research Group, LLC Willow Park Texas 76087 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04049266, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 18, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04049266 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →